270 related articles for article (PubMed ID: 23432763)
1. Phosphate handling by end-stage kidneys and benefits of residual renal function on phosphate removal in patients on haemodialysis.
Iwasawa H; Nakao T; Matsumoto H; Okada T; Nagaoka Y; Wada T
Nephrology (Carlton); 2013 Apr; 18(4):285-91. PubMed ID: 23432763
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Tokumoto M; Yoshida H; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Masutani K; Ooboshi H; Kitazono T
Ther Apher Dial; 2015 Feb; 19(1):73-80. PubMed ID: 25195562
[TBL] [Abstract][Full Text] [Related]
3. Lower serum fibroblast growth factor-23 levels may suggest malnutrition in maintenance haemodialysis patients.
Mizuiri S; Nishizawa Y; Yamashita K; Ono K; Oda M; Usui K; Shigemoto K
Nephrology (Carlton); 2014 Sep; 19(9):568-73. PubMed ID: 24947687
[TBL] [Abstract][Full Text] [Related]
4. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation.
Tomida K; Hamano T; Ichimaru N; Fujii N; Matsui I; Nonomura N; Tsubakihara Y; Rakugi H; Takahara S; Isaka Y
Bone; 2012 Oct; 51(4):729-36. PubMed ID: 22796419
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.
Phelps KR; Mason DL
Am J Nephrol; 2018; 47(5):343-351. PubMed ID: 29779023
[TBL] [Abstract][Full Text] [Related]
6. Association of circulating fibroblast growth factor-23 with renal phosphate excretion among hemodialysis patients with residual renal function.
Wang M; You L; Li H; Lin Y; Zhang Z; Hao C; Chen J
Clin J Am Soc Nephrol; 2013 Jan; 8(1):116-25. PubMed ID: 23085728
[TBL] [Abstract][Full Text] [Related]
7. Progression of residual renal function with an increase in dialysis: haemodialysis versus peritoneal dialysis.
Teruel-Briones JL; Fernández-Lucas M; Rivera-Gorrin M; Ruiz-Roso G; Díaz-Domínguez M; Rodríguez-Mendiola N; Quereda-Rodríguez-Navarro C
Nefrologia; 2013; 33(5):640-9. PubMed ID: 24089155
[TBL] [Abstract][Full Text] [Related]
8. Serum level of fibroblast growth factor 23 in maintenance renal transplant patients.
Sánchez Fructuoso AI; Maestro ML; Pérez-Flores I; Valero R; Rafael S; Veganzones S; Calvo N; De la Orden V; De la Flor JC; Valga F; Vidaurreta M; Fernández-Pérez C; Barrientos A
Nephrol Dial Transplant; 2012 Nov; 27(11):4227-35. PubMed ID: 23144073
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in renal tubular phosphate handling in children with sickle cell disease.
Raj VM; Freundlich M; Hamideh D; Alvarez O; Seeherunvong W; Abitbol C; Katsoufis C; Chandar J; Ruiz P; Zilleruelo G
Pediatr Blood Cancer; 2014 Dec; 61(12):2267-70. PubMed ID: 25132581
[TBL] [Abstract][Full Text] [Related]
10. Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.
Young A; Hodsman AB; Boudville N; Geddes C; Gill J; Goltzman D; Jassal SV; Klarenbach S; Knoll G; Muirhead N; Prasad GV; Treleaven D; Garg AX;
Am J Kidney Dis; 2012 Jun; 59(6):761-9. PubMed ID: 22093959
[TBL] [Abstract][Full Text] [Related]
11. Diabetes modifies effect of high-phosphate diet on fibroblast growth factor-23 in chronic kidney disease.
Muras K; Masajtis-Zagajewska A; Nowicki M
J Clin Endocrinol Metab; 2013 Dec; 98(12):E1901-8. PubMed ID: 24092829
[TBL] [Abstract][Full Text] [Related]
12. Renal function and tubular phosphate handling in long-term cyclosporine- and tacrolimus-based immunosuppression in kidney transplantation.
Falkiewicz K; Kamińska D; Nahaczewska W; Boratyńska M; Owczarek H; Klinger M; Woźniak M; Patrzałek D; Szyber P
Transplant Proc; 2006; 38(1):119-22. PubMed ID: 16504680
[TBL] [Abstract][Full Text] [Related]
13. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
[TBL] [Abstract][Full Text] [Related]
14. Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.
Yamada S; Tsuruya K; Taniguchi M; Yoshida H; Tokumoto M; Hasegawa S; Tanaka S; Eriguchi M; Nakano T; Kitazono T
Ther Apher Dial; 2014 Oct; 18(5):383-90. PubMed ID: 24674095
[TBL] [Abstract][Full Text] [Related]
15. Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients.
Viaene L; Bammens B; Meijers BK; Vanrenterghem Y; Vanderschueren D; Evenepoel P
Nephrol Dial Transplant; 2012 May; 27(5):2017-22. PubMed ID: 22025115
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor 23 and markers of mineral metabolism in individuals with preserved renal function.
Dhayat NA; Ackermann D; Pruijm M; Ponte B; Ehret G; Guessous I; Leichtle AB; Paccaud F; Mohaupt M; Fiedler GM; Devuyst O; Pechère-Bertschi A; Burnier M; Martin PY; Bochud M; Vogt B; Fuster DG
Kidney Int; 2016 Sep; 90(3):648-57. PubMed ID: 27370409
[TBL] [Abstract][Full Text] [Related]
17. A prospective study of fibroblast growth factor-23 in children with chronic kidney disease.
Magnusson P; Hansson S; Swolin-Eide D
Scand J Clin Lab Invest; 2010 Feb; 70(1):15-20. PubMed ID: 19929273
[TBL] [Abstract][Full Text] [Related]
18. The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit.
Davenport A; Gardner C; Delaney M;
Nephrol Dial Transplant; 2010 Mar; 25(3):897-901. PubMed ID: 19875379
[TBL] [Abstract][Full Text] [Related]
19. Reduced phosphate reabsorption unrelated to parathyroid hormone after renal transplantation: implications for the pathogenesis of hyperparathyroidism in chronic renal failure.
Parfitt AM; Kleerekoper M; Cruz C
Miner Electrolyte Metab; 1986; 12(5-6):356-62. PubMed ID: 3543637
[TBL] [Abstract][Full Text] [Related]
20. Acid Load and Phosphorus Homeostasis in CKD.
Khairallah P; Isakova T; Asplin J; Hamm L; Dobre M; Rahman M; Sharma K; Leonard M; Miller E; Jaar B; Brecklin C; Yang W; Wang X; Feldman H; Wolf M; Scialla JJ;
Am J Kidney Dis; 2017 Oct; 70(4):541-550. PubMed ID: 28645705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
